Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells

Tao Lu, Lyudmila G. Burdelya, Shannon M. Swiatkowski, Alexander D. Boiko, Philip H. Howe, George R. Stark, Andrei V. Gudkov

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

The basis of constitutive activation of NF-κB, essential for survival and resistance to apoptosis in many tumors, is not well understood. We find that transforming growth factor β2 (TGFβ2), predominantly in its latent form, is secreted by several different types of tumor cell lines that exhibit constitutively active NF-κB and that TGFβ2 potently stimulates the activation of NF-κB in reporter cells. Suppression of TGFβ2 expression by small interfering RNA kills prostate cancer PC3 cells, indicating that the TGFβ2-NF-κB pathway is important for their viability. These findings identify TGFβ2 as a potential target for therapeutic strategies to inhibit the growth of tumor cells that depend on constitutively active NF-κB, or to sensitize them to treatment with cytotoxic drugs.

Original languageEnglish (US)
Pages (from-to)7112-7117
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume101
Issue number18
DOIs
StatePublished - May 4 2004
Externally publishedYes

Fingerprint

Transforming Growth Factors
Apoptosis
Neoplasms
Tumor Cell Line
Small Interfering RNA
Prostatic Neoplasms
Growth
Pharmaceutical Preparations

Keywords

  • ELISA
  • Prostate cancer
  • Smad
  • Small interfering RNA

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells. / Lu, Tao; Burdelya, Lyudmila G.; Swiatkowski, Shannon M.; Boiko, Alexander D.; Howe, Philip H.; Stark, George R.; Gudkov, Andrei V.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 18, 04.05.2004, p. 7112-7117.

Research output: Contribution to journalArticle

Lu, Tao ; Burdelya, Lyudmila G. ; Swiatkowski, Shannon M. ; Boiko, Alexander D. ; Howe, Philip H. ; Stark, George R. ; Gudkov, Andrei V. / Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells. In: Proceedings of the National Academy of Sciences of the United States of America. 2004 ; Vol. 101, No. 18. pp. 7112-7117.
@article{170d62234a4b4e69adba7f8963548b03,
title = "Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells",
abstract = "The basis of constitutive activation of NF-κB, essential for survival and resistance to apoptosis in many tumors, is not well understood. We find that transforming growth factor β2 (TGFβ2), predominantly in its latent form, is secreted by several different types of tumor cell lines that exhibit constitutively active NF-κB and that TGFβ2 potently stimulates the activation of NF-κB in reporter cells. Suppression of TGFβ2 expression by small interfering RNA kills prostate cancer PC3 cells, indicating that the TGFβ2-NF-κB pathway is important for their viability. These findings identify TGFβ2 as a potential target for therapeutic strategies to inhibit the growth of tumor cells that depend on constitutively active NF-κB, or to sensitize them to treatment with cytotoxic drugs.",
keywords = "ELISA, Prostate cancer, Smad, Small interfering RNA",
author = "Tao Lu and Burdelya, {Lyudmila G.} and Swiatkowski, {Shannon M.} and Boiko, {Alexander D.} and Howe, {Philip H.} and Stark, {George R.} and Gudkov, {Andrei V.}",
year = "2004",
month = "5",
day = "4",
doi = "10.1073/pnas.0402048101",
language = "English (US)",
volume = "101",
pages = "7112--7117",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "18",

}

TY - JOUR

T1 - Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells

AU - Lu, Tao

AU - Burdelya, Lyudmila G.

AU - Swiatkowski, Shannon M.

AU - Boiko, Alexander D.

AU - Howe, Philip H.

AU - Stark, George R.

AU - Gudkov, Andrei V.

PY - 2004/5/4

Y1 - 2004/5/4

N2 - The basis of constitutive activation of NF-κB, essential for survival and resistance to apoptosis in many tumors, is not well understood. We find that transforming growth factor β2 (TGFβ2), predominantly in its latent form, is secreted by several different types of tumor cell lines that exhibit constitutively active NF-κB and that TGFβ2 potently stimulates the activation of NF-κB in reporter cells. Suppression of TGFβ2 expression by small interfering RNA kills prostate cancer PC3 cells, indicating that the TGFβ2-NF-κB pathway is important for their viability. These findings identify TGFβ2 as a potential target for therapeutic strategies to inhibit the growth of tumor cells that depend on constitutively active NF-κB, or to sensitize them to treatment with cytotoxic drugs.

AB - The basis of constitutive activation of NF-κB, essential for survival and resistance to apoptosis in many tumors, is not well understood. We find that transforming growth factor β2 (TGFβ2), predominantly in its latent form, is secreted by several different types of tumor cell lines that exhibit constitutively active NF-κB and that TGFβ2 potently stimulates the activation of NF-κB in reporter cells. Suppression of TGFβ2 expression by small interfering RNA kills prostate cancer PC3 cells, indicating that the TGFβ2-NF-κB pathway is important for their viability. These findings identify TGFβ2 as a potential target for therapeutic strategies to inhibit the growth of tumor cells that depend on constitutively active NF-κB, or to sensitize them to treatment with cytotoxic drugs.

KW - ELISA

KW - Prostate cancer

KW - Smad

KW - Small interfering RNA

UR - http://www.scopus.com/inward/record.url?scp=2342510148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342510148&partnerID=8YFLogxK

U2 - 10.1073/pnas.0402048101

DO - 10.1073/pnas.0402048101

M3 - Article

VL - 101

SP - 7112

EP - 7117

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 18

ER -